Bristol Myers Squibb Stock - Thursday snapshot with chart and consensus lens
18.06.2026 - 21:21:40 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 19:20 UTC. Details in the imprint.
Bristol Myers Squibb (US0897961004) remains a key U.S. large-cap pharma stock on the New York Stock Exchange. With no fresh investor-relations or major wire headlines this Thursday, attention shifts to the technical setup and analyst consensus on the name.
Background and live data on Bristol Myers Squibb stock
All recent corporate disclosures, quotes and archive news on Bristol Myers Squibb stock can be found in the dedicated topic area.
Thursday without fresh catalysts
There are no new ad-hoc statements, press releases or regulatory filings from Bristol-Myers Squibb Company on its investor-relations page or from major wires like Reuters and Bloomberg this Thursday.
The most recent corporate planning signal is the announcement that Bristol Myers Squibb will report its second-quarter 2026 results on 07/30/2026, with a conference call scheduled for 8:15 a.m. ET.
What recent data show on chart and sentiment
According to a recent overview, Bristol Myers Squibb shares changed hands around $40.00 on the New York Stock Exchange in Thursday midday trading, representing a market capitalization of roughly $81 billion.
That same snapshot confirms the stock’s inclusion in the Standard & Poor's 500 index, underlining its role as a core U.S. healthcare component for many diversified portfolios.
Analyst stance and consensus snapshot
Consensus data compiled by MarketBeat indicate that 19 Wall Street analysts covering Bristol Myers Squibb currently assign a composite rating of "Hold," with 8 Buys, 10 Holds and 1 Sell in the distribution.
On that platform, the average 12-month price target stands around $55.41 per share, based on the latest closing data and reflecting a cautious but not negative stance toward the stock.
How Bristol Myers Squibb earns its money
Bristol Myers Squibb generates most of its revenue from prescription pharmaceuticals, including oncology, hematology, immunology and cardiovascular therapies, with key drugs such as Eliquis and Opdivo among its largest current revenue contributors.
Where the stock trades today
The shares of Bristol Myers Squibb (US0897961004) trade on the New York Stock Exchange at around $40.00 as of 06/18/2026, 11:30 ET.
Key facts on Bristol Myers Squibb stock
- Company: Bristol-Myers Squibb Company
- ISIN: US0897961004
- WKN: 850501
- Ticker: BMY
- Venue: New York Stock Exchange
- Price (as of 06/18/2026, 11:30 ET): 40.00 USD
- Market cap: 81,000,000,000 USD (as of 06/18/2026)
- Sector / Industry: Health Care / Pharmaceuticals
- Index membership: S&P 500
- Next earnings date: 07/30/2026
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
